The CaMKKβ inhibitor STO-609 also prevented induction of mitochondrial function by IGF-1 but this effect did not reach statistical significance ( Figure 3 A,B).
← all excerpts
Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes.
1
—
—